1.355SEK-5.24%Mkt Cap: 91.77M SEKP/E: —Last update: 2026-06-01
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXi…
Industry Peers
Specialty Chemicals102.39BEURP/E 29.2
72.86BUSDP/E 28.4
70.67BUSDP/E 33.9
62.19BUSDP/E 29.4
40.39BTRY—
26.28BCHFP/E 24.7
24.83BUSDP/E 16.0
24.56BSEKP/E 13.3
Indicators:|
Key Statistics
Company
Market Cap91.77M SEK
Enterprise Value92.87M SEK
Revenue (TTM)18.89M SEK
Gross Profit9.08M SEK
Net Income (TTM)-17.63M SEK
Revenue/Share0.3130 SEK
Last Price1.355 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountrySE
SectorBasic Materials
IndustrySpecialty Chemicals
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.83
EV/Revenue4.92
P/S5.13
P/B1.63
EPS (TTM)-0.25
EPS (Forward)—
52W Range
1.1357% of range4.100
52W High4.100 SEK
52W Low1.135 SEK
Profitability
Gross Margin49.23%
Oper. Margin-73.86%
EBITDA Margin-50.01%
Profit Margin-95.59%
ROE-33.36%
ROA-28.86%
Growth
Revenue Growth13.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.35M SEK
CapEx (TTM)4.66M SEK
FCF Margin-52.29%
FCF Yield-10.76%
Net Debt-4.00M SEK
Net Debt/EBITDA0.42
Balance Sheet
Debt/Equity0.09
Current Ratio4.23
Quick Ratio2.46
Book Value/Sh0.8780 SEK
Cash/Share0.0590 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.67.73M
Float47.97M
Insiders21.38%
Institutions28.79%
Technical
SMA 501.437 (-5.7%)
SMA 2002.134 (-36.5%)
Beta-0.71
S&P 52W Chg27.70%
Avg Vol (30d)42.58K
Avg Vol (10d)44.36K
Technical Indicators
RSI (14)48.2
MACD0.0157
MACD Signal0.0206
MACD Hist.-0.0049
BB Upper1.606 SEK
BB Middle1.451 SEK
BB Lower1.295 SEK
BB Width21.46%
ATR (14)0.0917 SEK
Vol Ratio (20d)0.21x